SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-033501
Filing Date
2018-05-15
Accepted
2018-05-15 17:14:16
Documents
69
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a18-8701_110q.htm 10-Q 605960
2 EX-4.1 a18-8701_1ex4d1.htm EX-4.1 170948
3 EX-10.1 a18-8701_1ex10d1.htm EX-10.1 182224
4 EX-10.2 a18-8701_1ex10d2.htm EX-10.2 82231
5 EX-31.1 a18-8701_1ex31d1.htm EX-31.1 12385
6 EX-31.2 a18-8701_1ex31d2.htm EX-31.2 11965
7 EX-32.1 a18-8701_1ex32d1.htm EX-32.1 5317
8 EX-32.2 a18-8701_1ex32d2.htm EX-32.2 4907
  Complete submission text file 0001104659-18-033501.txt   4578646

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ctrv-20180331.xml EX-101.INS 781151
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctrv-20180331.xsd EX-101.SCH 47549
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctrv-20180331_cal.xml EX-101.CAL 31079
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctrv-20180331_def.xml EX-101.DEF 192005
13 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ctrv-20180331_lab.xml EX-101.LAB 424214
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctrv-20180331_pre.xml EX-101.PRE 315035
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 18837748
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1